Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
Dyne Therapeutics (Nasdaq: DYN), a clinical-stage neuromuscular disease company, has announced its upcoming participation in the Oppenheimer 35th Annual Healthcare Life Sciences Conference. The company's management will engage in a virtual fireside chat scheduled for Tuesday, February 11, 2025, at 4:00 p.m. ET.
Interested parties can access a live webcast of the presentation through the Investors & Media section of Dyne's website. The presentation recording will remain available for 90 days following the event on the company's investor relations platform at https://investors.dyne-tx.com/news-and-events/events-and-presentations.
Dyne Therapeutics (Nasdaq: DYN), un'azienda in fase clinica che si occupa di malattie neuromuscolari, ha annunciato la sua prossima partecipazione alla 35ª Conferenza Annuale sulle Scienze della Salute di Oppenheimer. Il management dell'azienda parteciperà a una chiacchierata virtuale programmata per martedì 11 febbraio 2025, alle 16:00 ET.
Le parti interessate possono accedere a una diretta streaming della presentazione attraverso la sezione Investitori e Media del sito web di Dyne. La registrazione della presentazione rimarrà disponibile per 90 giorni dopo l'evento sulla piattaforma delle relazioni con gli investitori dell'azienda all'indirizzo https://investors.dyne-tx.com/news-and-events/events-and-presentations.
Dyne Therapeutics (Nasdaq: DYN), una empresa en etapa clínica dedicada a enfermedades neuromusculares, ha anunciado su próxima participación en la 35ª Conferencia Anual de Ciencias de la Salud de Oppenheimer. La gerencia de la empresa participará en un chat virtual que está programado para el martes 11 de febrero de 2025, a las 4:00 p.m. ET.
Las partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección de Inversores y Medios del sitio web de Dyne. La grabación de la presentación estará disponible durante 90 días tras el evento en la plataforma de relaciones con inversores de la empresa en https://investors.dyne-tx.com/news-and-events/events-and-presentations.
Dyne Therapeutics (Nasdaq: DYN), 신경근육 질환에 대한 임상 단계의 회사가 오펜하이머 제35회 연례 건강 과학 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사 관리진은 2025년 2월 11일 화요일 오후 4시 ET에 예정된 가상 대화에 참여할 것입니다.
관심 있는 분들은 Dyne의 웹사이트의 투자자 및 미디어 섹션을 통해 프리젠테이션의 실시간 웹캐스트에 접속할 수 있습니다. 프리젠테이션 녹화는 사건 후 90일 동안 회사의 투자자 관계 플랫폼에서 제공됩니다: https://investors.dyne-tx.com/news-and-events/events-and-presentations.
Dyne Therapeutics (Nasdaq: DYN), une entreprise en phase clinique spécialisée dans les maladies neuromusculaires, a annoncé sa prochaine participation à la 35e Conférence Annuelle sur les Sciences de la Santé d'Oppenheimer. La direction de l'entreprise participera à un chat virtuel prévu pour mardi 11 février 2025, à 16h00 ET.
Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Investisseurs et Médias du site web de Dyne. L'enregistrement de la présentation restera disponible pendant 90 jours après l'événement sur la plateforme des relations avec les investisseurs de l'entreprise à l'adresse suivante : https://investors.dyne-tx.com/news-and-events/events-and-presentations.
Dyne Therapeutics (Nasdaq: DYN), ein Unternehmen in klinischer Phase, das sich mit neuromuskulären Erkrankungen beschäftigt, hat seine bevorstehende Teilnahme an der 35. Jahreskonferenz für Gesundheitswissenschaften von Oppenheimer angekündigt. Das Management des Unternehmens wird an einem virtuellen Fireside-Chat teilnehmen, der für dienstag, den 11. Februar 2025, um 16:00 Uhr ET geplant ist.
Interessierte Parteien können über den Bereich Investoren & Medien der Website von Dyne auf einen Live-Stream der Präsentation zugreifen. Die Aufzeichnung der Präsentation wird 90 Tage nach der Veranstaltung auf der Investor Relations-Plattform des Unternehmens unter https://investors.dyne-tx.com/news-and-events/events-and-presentations verfügbar bleiben.
- None.
- None.
WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present during a virtual fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 at 4:00 p.m. ET.
A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days following the presentation.
About Dyne Therapeutics
Dyne Therapeutics is focused on discovering and advancing innovative life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Leveraging the modularity of its FORCE™ platform, Dyne is developing targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system (CNS). Dyne has a broad pipeline for neuromuscular diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. For more information, please visit https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Contacts:
Investors
Mia Tobias
ir@dyne-tx.com
Media
Stacy Nartker
snartker@dyne-tx.com
781-317-1938
FAQ
When is Dyne Therapeutics (DYN) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors watch Dyne Therapeutics' (DYN) Oppenheimer Conference presentation?
How long will the replay of DYN's Oppenheimer Conference presentation be available?
What type of presentation will DYN deliver at the Oppenheimer Healthcare Conference 2025?
